investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Toward personalized immunotherapy: identifying tumour-specific factors that dictate the response of spontaneous mammary cancers to T cells
Brad Nelson
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Brad Nelson
BC Cancer Agency
Vancouver, Canada
Related projects
Carol Prives
Roles and Regulation of p53
Breast
Svetlana Bortnik
The effects of autophagy knockdown in breast cancer cells using in vivo xenograft models
Breast
Susan E Erdman
GI Tract Dysbiosis and Breast Cancer
Breast
Daniel Durocher
Understanding DNA repair pathway choice control
Breast
Dharmendra Dingar
In vivo BioID identifies novel c-MYC interacting partners
Breast
Sergey Korolev
Structural and Functional Studies of Tumor Suppressor Proteins PALB2 and BRCA2
Breast
Munira Basrai
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
Breast
Mien-Chie Hung
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
Breast
Lalage Wakefield
Development of TGF-beta antagonists for cancer therapy
Breast
